Citation Impact
Citing Papers
The Runx1 Transcription Factor Inhibits the Differentiation of Naive CD4 + T Cells into the Th2 Lineage by Repressing GATA3 Expression
2003
Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction
2020 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
2013 StandoutScienceNobel
Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis
2018 StandoutNobel
Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBFα/AML/PEBP2α) dependent activation of tissue-specific gene transcription
2000
Breast cancer
2019 Standout
Macrophage activation syndrome and COVID-19
2020
Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn’s disease: a case report
2016 StandoutNobel
Molecular mechanisms and clinical management of cancer bone metastasis
2020
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
Long COVID: major findings, mechanisms and recommendations
2023 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Structural Analyses of DNA Recognition by the AML1/Runx-1 Runt Domain and Its Allosteric Control by CBFβ
2001
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Peptide Epitope Identification by Affinity Selection on Bacteriophage MS2 Virus-Like Particles
2011
Indispensable Role of the Runx1-Cbfβ Transcription Complex for In Vivo-Suppressive Function of FoxP3+ Regulatory T Cells
2009 StandoutNobel
Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1
2007 StandoutNatureNobel
Insect hemocytes and their role in immunity
2002 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Improving de novo protein binder design with deep learning
2023 StandoutNobel
CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
2019 StandoutNobel
Structural basis of immunosuppression by the therapeutic antibody daclizumab
2010
Targeting B cell receptor signalling in cancer: preclinical and clinical advances
2018
Differential effects of inhibition of bone morphogenic protein (BMP) signalling on T‐cell activation and differentiation
2011 StandoutNobel
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
EGF–ERBB signalling: towards the systems level
2006 Standout
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
2012 Nature
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Epigenetics in cancer
2009 Standout
Evolution of a designed protein assembly encapsulating its own RNA genome
2017 StandoutNatureNobel
Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia
2002
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Novel Roles for MLH3 Deficiency and TLE6-Like Amplification in DNA Mismatch Repair-Deficient Gastrointestinal Tumorigenesis and Progression
2008 StandoutNobel
Liquid biopsy
2015
Drosophila innate immunity: an evolutionary perspective
2002 StandoutNobel
Targeting Epidermal Growth Factor Receptor in Head and Neck Cancer
2022
Global burden of liver disease: 2023 update
2023 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
Targeted drug delivery for cancer therapy: the other side of antibodies
2012
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
2002 Standout
The evolution and genetics of innate immunity
2001 StandoutNobel
ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome
2007 Standout
Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells
2003
The Immunology of Macrophage Activation Syndrome
2019
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
2020
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Defining trained immunity and its role in health and disease
2020 Standout
Bispecific antibodies: a mechanistic review of the pipeline
2019
Artificial intelligence in healthcare
2018 Standout
Mechanisms of resistance to CAR T cell therapy
2019
Liquid Biopsies and Cancer Immunotherapy
2018
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
Targeting the B-cell receptor signaling pathway in B lymphoid malignancies
2014
Functional Roles of the IgM Fc Receptor in the Immune System
2019 StandoutNobel
PVF2, a PDGF/VEGF‐like growth factor, induces hemocyte proliferation in Drosophila larvae
2002 StandoutNobel
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
2018 StandoutNobel
Deacetylated sialic acids modulates immune mediated cytotoxicity via the sialic acid-Siglec pathway
2021 StandoutNobel
Molecular Pathways: Sensitivity and Resistance to Anti-EGFR Antibodies
2015
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy
2014
Cytokine Storm
2020 Standout
CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell response
2013
Chimeric Antigen Receptor Therapy
2018 Standout
Tumor Antigen Escape from CAR T-cell Therapy
2018
Modular repeat protein sculpting using rigid helical junctions
2020 StandoutNobel
Characterization of a Hepatitis Outbreak in Children, 2021 to 2022
2022
The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion
2000
Resistance to Anti-EGFR Therapy in Colorectal Cancer: From Heterogeneity to Convergent Evolution
2014
Specification of Drosophila Hematopoietic Lineage by Conserved Transcription Factors
2000 Science
Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification
2017
A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi
2013
GENETICS OF MYELOID LEUKEMIAS
2002
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
2023 StandoutNobel
MatInspector and beyond: promoter analysis based on transcription factor binding sites
2005 Standout
Works of Mascha Binder being referenced
Identification of Their Epitope Reveals the Structural Basis for the Mechanism of Action of the Immunosuppressive Antibodies Basiliximab and Daclizumab
2007
Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation
2020
Functional Dissection of the Epidermal Growth Factor Receptor Epitopes Targeted by Panitumumab and Cetuximab
2012
Phenotypic Detection of Clonotypic B Cells in Multiple Myeloma by Specific Immunoglobulin Ligands Reveals their Rarity in Multiple Myeloma
2012
B‐cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia
2010
Stereotypical Chronic Lymphocytic Leukemia B-Cell Receptors Recognize Survival Promoting Antigens on Stromal Cells
2010
Critical Imbalance of TNF-α and Soluble TNF Receptor 1 in a Patient with Macrophage Activation Syndrome: Potential Implications for Diagnostics and Treatment
2012
The epitope recognized by rituximab
2006
Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer
2015
T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker
2016
From Online Data Collection to Identification of Disease Mechanisms: The IL-1ß, IL-6 and TNF-α Cytokine Triad Is Associated With Post-Acute Sequelae of COVID-19 in a Digital Research Cohort
2021
Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL
2014
Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma
2016
Resistance to anti-CD19/CD3 BiTE in acute lymphoblastic leukemia may be mediated by disrupted CD19 membrane trafficking
2016
Core-binding factor: a central player in hematopoiesis and leukemia.
1999